Retina. 2009 Jun;29(6):740-9. doi: 10.1097/IAE.0b013e3181a0be1d. Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results. Gharbiya M1, Allievi F, Recupero V, Martini D, Mazzeo L, Gabrieli CB. PURPOSE: To evaluate the short-term efficacy and safety of intravitreal bevacizumab for the treatment of retinal angiomatous proliferation. METHODS: Seventeen eyes from 16 patients with newly diagnosed Leggi di piùBevacizumab Intravitreale per il trattamento delle proliferazioni retiniche angiomatose: risultati a 12 mesi[…]